Kenko International

After 20 years of Clinical Research, Business Development, Strategic Partnering and Licensing, especially, Ineke Rijnhout, CEO of Kenko, is now putting her skills and experience to work to build an innovative biotech business as one of the objectives in the GYM project.

Ineke Rijnhout, will create relationships with life science investors, build a strong patent portfolio, and perform an in-depth market analysis. Together with GYM’s teams of excellence, Ineke Rijnhout is designing a business strategy, including a clinical development roadmap, to accelerate the development of a groundbreaking cell therapy for genetic muscle disorders for which currently no treatment exists.

Ineke Rijnhout

CEO, Research interests: medicine development, cell therapy, orphan diseases Contribution to GYM: Clinical Development Plan, Business & IP Strategy; WP T1, WP T2, WP T3, WP C

Generate your Muscle

Our mission is to develop and produce an innovative stem cell therapy for muscle repair and regeneration.

Be a part of our research progress and contribute

If you are interested in our project and our aims and if you have questions, you want to contribute or you want to join forces with us, please fill in the contact form. We will come back to you as quickly as we can.

Kenko International